Thursday, December 5, 2013

Cepheid - Barchart's Chart of the Day

Cepheid (CPHD) is the Chart of the Day.  The laboratory analytical instrument stock has a Trend Spotter buy, a Weighted Alpha of 52.40+ and is up 45.53% in the last year.

The Chart of the Day is Cepheid (CPHD).  I found the stock by sorting today's New High List for frequency, eliminating the stocks that haven't had positive gains for both the last week and month.  I used the Flipchart feature to review the charts.  Since the Trend Spotter signaled a buy in 10/18 the stock gained 13.57%.

The Company develops, manufactures and markets microfluidic systems that integrate, automate and accelerate biological testing. Their systems are miniaturized instruments that analyze complex biological samples in a disposable cartridge by combining molecular biology with microfluidic technology that processes small quantities of liquid, typically using components fabricated with computer chip technology. These systems rapidly perform all of the steps required to analyze complex biological samples.



Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

Barchart technical indicators:

  • 96% Barchart technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 15 new highs and up 11.79% in the last month
  • Relative Strength Index 77.87%
  • Barchart computes a technical support level at 45.01
  • Recently traded at 46.19 with a 50 day moving average of 41.06
Fundamental factors:
  • Market Cap $3.12 billion
  • P/E 1,524
  • Analysts predict revenue will grow 17.80% this year and another 14.60% next year
  • Earnings are estimated to increase 26.70% this year, an additional 109.10% next year and continue to increase 15.00% annually for the next 5 years
  • Wall Street analysts issued 5 strong buy, 6 buy, 5 hold, 1 under perform and a single sell recommendation on this stock
  • Financial Strength is B
This stock is about to begin to show steady profits.  Watch the 50 day moving average for signs of weakness,

No comments:

Post a Comment